Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.390
-0.030 (-2.11%)
At close: Nov 20, 2024, 4:00 PM
1.430
+0.040 (2.88%)
After-hours: Nov 20, 2024, 5:41 PM EST
Actinium Pharmaceuticals Employees
Actinium Pharmaceuticals had 49 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
49
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,653
Profits / Employee
-$835,000
Market Cap
43.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
Achilles Therapeutics | 215 |
Rapid Micro Biosystems | 193 |
OncoCyte | 46 |
Calidi Biotherapeutics | 41 |
Gain Therapeutics | 32 |
SCYNEXIS | 29 |
Serina Therapeutics | 11 |
ATNM News
- 2 days ago - SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player - PRNewsWire
- 2 days ago - Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024 - PRNewsWire
- 16 days ago - Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 16 days ago - Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors - PRNewsWire
- 17 days ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud - Accesswire
- 18 days ago - Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 21 days ago - Actinium Pharmaceuticals, Inc. Is Being Investigated For Violations Of Securities Laws And Affected Shareholders Should Contact The Schall Law Firm - Accesswire
- 22 days ago - The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Actinium Pharmaceuticals Inc For Fraud - Accesswire